Question special

Thanks to the authors and experts for joining us for this discussion! This study excitingly identifies a subpopulation of COPD patients with an eosinophilic phenotype who may benefit from targeted therapies.
Do you routinely screen all of your patients with COPD for eosinophilia? For patients with frequent exacerbations, how often should we screen given that historical eosinophil counts seem to play a role as well as current levels of blood eosinophilia?